XML 32 R19.htm IDEA: XBRL DOCUMENT
v3.25.3

Lessor Leases | 9 Months Ended
--- | ---
Sep. 30, 2025
Leases [Abstract] |
Lessor Leases | Lessor Leases Sales-Type Leases The Company enters into non-cancelable sales-type lease arrangements with the leases varying in length from one to ten years. The Company optimizes cash flows by selling a majority of its sales-type leases, other than those relating to U.S. government hospitals and SaaS and Expert Services products, including Central Pharmacy Dispensing Service and IV C ompounding Service, to third-party leasing finance companies on a non-recourse basis. The Company generally has no obligation to the leasing company once the lease has been sold. The following table presents the Company’s income recognized from sales-type leases:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
| (In thousands)
Sales-type lease revenues | $ | 4,562 |  |  | $ | 6,952 |  |  | $ | 17,011 |  |  | $ | 25,564 |
Cost of sales-type lease revenues | (2,892) |  |  | (3,912) |  |  | (9,931) |  |  | (15,209) |
Selling profit on sales-type lease revenues | $ | 1,670 |  |  | $ | 3,040 |  |  | $ | 7,080 |  |  | $ | 10,355 |
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components:
| September 30, 2025 |  | December 31, 2024
| (In thousands)
Net minimum lease payments to be received | $ | 80,118 |  |  | $ | 77,976 |
Less: Unearned interest income portion | (12,406) |  |  | (12,757) |
Net investment in sales-type leases | 67,712 |  |  | 65,219 |
Less: Current portion (1) | (13,394) |  |  | (12,475) |
Long-term investment in sales-type leases, net | $ | 54,318 |  |  | $ | 52,744 |
_________________________________________________ (1) The current portion of the net investment in sales-type leases is included in other current assets in the Condensed Consolidated Balance Sheets. The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value. The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Condensed Consolidated Balance Sheets was as follows:
| September 30, 2025
| (In thousands)
Remaining three months of 2025 | $ | 4,226 |
2026 | 16,222 |
2027 | 15,204 |
2028 | 14,093 |
2029 | 11,454 |
Thereafter | 18,919 |
Total future minimum sales-type lease payments | 80,118 |
Present value adjustment | (12,406) |
Total net investment in sales-type leases | $ | 67,712 |

X
- References No definition available. + Details
Name: | us-gaap_LeasesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of lessor's sales-type leases. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-30/tableOfContent + Details
Name: | us-gaap_LessorSalesTypeLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration